A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
There have been 117 flu-related deaths in North Carolina this season. According to NCDHHS, 51 new flu deaths were added to ...
RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...
In addition to the cold and flu, many are falling ill to RSV, COVID and norovirus this winter. How to know what you have.
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.